Dexamethasone Linked To Reduced Mortality Among Patients Hospitalized With COVID-19, Study Suggests

Infectious Disease Advisor (1/24, Basilio) reported, “Dexamethasone is associated with reduced mortality among patients hospitalized with COVID-19, particularly those requiring respiratory support, according to study findings.” Researchers found that “dexamethasone was associated with survival benefit among patients requiring invasive mechanical ventilation at 28 days...and 1 year.” The findings were published in BMC Infectious Diseases.